Crinetics Pharma Appoints Alan Krasner Chief Medical Officer

Xconomy San Diego — 

Alan Krasner has joined Crinetics Pharmaceuticals (NASDAQ: CRNX) as chief medical officer. Krasner comes to the San Diego biotech from Shire (NASDAQ: SHPG), where he was a senior medical director. His experience also includes posts at Biodel and Pfizer (NYSE: PFE). Crinetics develops treatments for rare endocrine diseases and endocrine-related tumors.